Insider Sale: Credo Director Trims Stake with $76-$79 Share Disposals
Rhea-AI Filing Summary
Credo Technology Group Holding (NASDAQ: CRDO) filed a Form 4 disclosing that director Lip-Bu Tan, through Walden Technology Ventures Investments II L.P., sold a total of 171,473 ordinary shares on 16 June 2025 across four tranches at weighted-average prices ranging from $76.6506 to $79.1236.
The transactions generated approximately $13.3 million in gross proceeds and reduced Walden’s indirect holding from about 785,198 to 613,725 shares, a decline of roughly 22%. Tan also continues to hold 133,583 shares via the Lip-Bu Tan and Ysa Loo Trust, 39,736 shares through A&E Investment LLC, and 53,574 shares directly.
No derivatives were transacted and the filing does not indicate that the sales were executed under a Rule 10b5-1 trading plan. No other material changes or risk factors were disclosed.
Positive
- None.
Negative
- Director Lip-Bu Tan sold 171,473 shares (~22% of his indirect Walden stake) on 06/16/25 for roughly $13.3 million at $76-$79 per share
- Filing does not indicate a Rule 10b5-1 trading plan, suggesting discretionary insider selling
Insights
TL;DR: ~$13 M discretionary insider sale trims indirect position by ~22%, tilting near-term sentiment negative.
The Form 4 shows four open-market trades totaling 171,473 CRDO shares at $76.65–$79.12 on 16 Jun 2025, worth about $13.3 million. Post-sale, Walden’s stake falls to 613,725 shares while other trusts and direct holdings remain intact, leaving Tan with ~840 K shares overall. The Rule 10b5-1 checkbox is unchecked, implying discretionary timing. Large disposals by directors often signal profit-taking or reduced conviction and may pressure the stock in the short run. However, the director retains a substantial holding, so long-term alignment persists. Overall impact skews negative but is not catastrophic.
FAQ
How many CRDO shares did Lip-Bu Tan sell on June 16 2025?
At what prices were the CRDO shares sold by the director?
What is Lip-Bu Tan’s remaining indirect holding in Walden Technology Ventures after the sale?
What is the director’s total beneficial ownership in CRDO after the reported transactions?
Were the sales executed under a Rule 10b5-1 trading plan?